Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes

Neuropsychiatric Disease and Treatment

Volumn 4, Issue 6, 2008, Pages 1277-1281

  Ikenouchi Sugita, Atsuko ^a   Yoshimura, Reiji ^a   Ueda, Nobuhisa ^a   Kodama, Yuki ^a   Umene Nakano, Wakako ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Brain derived neurotrophic factor; Neuropsychiatric syndrome of systemic lupus erythematosus; Organic brain change

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOPHOSPHAMIDE; PREDNISOLONE; QUETIAPINE; VALPROIC ACID;

ADULT; AGITATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENCEPHALITIS; HUMAN; INSOMNIA; MALE; MEMORY DISORDER; MOOD DISORDER; NEUROPSYCHIATRIC SYNDROME OF SYSTEMIC LUPUS ERYTHEMATOSUS; ORGANIC BRAIN SYNDROME; PARANOIA; PROGNOSIS; PROTEIN BLOOD LEVEL; PSYCHOPATHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 60249085547     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. [ACR] American College of Rheumatology. 1999. ACR ad hoc committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum, 42:599-608.
2. Berger C, Schabitz WR, Wolf M, et al. 2004. Hypotbermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp Neurol, 185:305-12.
3. Berton O, McClung CA, Krishnan V, et al. 2006. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311:864-8.
4. Chhatwal JP, Stanek-Rattiner L, Davis M, et al. 2006. Amygdala BDNF signating is required for consolidation but not encoding extinction. Nat Neurosci, 9:870-2.
5. Chiaretti A, Antonelli A, Piastra M, et al. 2004. Expression of neurotrophic factors in cerebrospinal fluid and plasma of children with viral and bacterial meningoencephalitis. Acta Paediatr, 93:1178-84.
6. Ciammola A, Sassone J, Cannella M, et al. 2007. Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am J Med Genet B Neuropsychiatr Genet, 144:574-7.
7. Egan MF, Kojima M, Callicot JH, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112:257-69.
8. Frey BN, Andreazza AC, Cereser KM, et al. 2006. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci, 79:281-6.
9. Hashimoto K, Koizumi H, Nakazato M, et al. 2005. Role of brain-derived neurotrophic factor in eating disorders: recent findings and its pathophysiological imptications. Prog Neuropsychopharmacol Biol Psychiatry, 20:499-504.
10. Hori H, Yoshimura R, Yamada Y, et al. 2007. Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients. Int Clin Psychopharmacol, 22:21-7.
11. Howells DW, Porritt M J, Wong JY, et al. 2000. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol, 166:127-35.
12. Ikenouchi A, Yoshimura R, Ikemura N, et al. 2006. Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report. Prog Neuropsychopharmacol Biol Psychiatry, 30:1359-63.
13. Jaconsen JPR and Mork A. 2006. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res, 1110:221-5.
14. Karege F, Schwald M, Cisse M, et al. 2002. Postnatal developmental profile o f brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett, 328:2614.
15. Laske C, Stransky E, Leyhe T, et al. 2006. Decreased brain-derived neurotrophic factor (BDNF)- and beta-thromboglobulin (beta-TG)- blood levels in Alzheimer's disease. Thromb Haemost, 96:102-3.
16. Lewin GR and Barde YA. 1996. Physiology of the neurotrophins. Annu Rev Neurosci, 19:289-317.
17. Martinowick K, Manji H, Lu B, et al. 2007. New insights into BDNF function in depression and anxiety. Nat Neurosci, 10:1089-93.
18. Nockher WA and Renz H. 2003. Neurotrophins in inflammatory lung diseases: modulators of cell differentiation and neuroimmune interactions. Cytokine Growth Factor Rev, 14:559-78.
19. Oroszi G, Lapteva L, Davis E, et al. 2006. The met66 allele of the functional val66met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Ann Rhenm Dis, 65:1330-5.
20. Pan W, Banks WA, Fasold MB, et al. 1998. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology, 37:1553-61.
21. Park SW, Lee SK, Kim JM, et al. 2006. Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats. Neurosci Lett, 402:25-9.
22. Shlomchik MJ, Madaio MP, Ni D, et al. 1994. The role of B cells in lpr/ lpr-induced autoimmunity. J Exp Med, 180:1295-306.
23. Trzepacz PT, Mittal D, Torres R, et al. 2001. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci, 13:22942.
24. Vega JA, García-Suárez O, Hannestad J, et al. 2003. Neurotrophins and the immune system. J Anat, 203:1-19.
25. Weinstock-Guttman B, Zivadinov R, Tamaño-Blanco M, et al. 2007. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. J Neuroimmunol, 188:167-74.
26. Yoshimura R, Mitoma M, Sugita A, et al. 2007. Effects of paroxetine or milnacipran on serum brain-derived neurotrophie factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry, 31:1034-7.